| 2026-02-26 | Mr. David DicksonMD, CEO & Director | 1,85M | 0,00 | Derivative Exercise and Retained Stock | - | 15,16M | 13,87% |
| 2026-02-26 | Mr. David DicksonMD, CEO & Director | -1,07M | 0,00 | Derivative Exercise and Sale | - | 15,16M | - |
| 2026-02-26 | Mr. David DicksonMD, CEO & Director | -2,92M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-12-18 | Dr. Robert TrzebskiIndependent Non-Executive Director | 2,88M | 0,00 | Derivative Exercise and Retained Stock | - | 2,88M | - |
| 2025-12-18 | Mr. Geoffrey Stuart CrowNon-Executive Chairman of the Board | 2,88M | 0,00 | Derivative Exercise and Retained Stock | - | 24,88M | 13,11% |
| 2025-12-03 | Dr. Robert TrzebskiIndependent Non-Executive Director | 2,88M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-03 | Mr. David DicksonMD, CEO & Director | 19,23M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-03 | Mr. David DicksonMD, CEO & Director | 19,23M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-03 | Mr. Geoffrey Stuart CrowNon-Executive Chairman of the Board | 2,88M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-06 | Mr. David DicksonMD, CEO & Director | 10,80M | 254,73k | Kauf | 0,02 | 13,31M | 429,88% |
| 2025-10-31 | Mr. Geoffrey Stuart CrowNon-Executive Chairman of the Board | 5,00M | 0,00 | Open Market Derivative Acquisition | - | - | - |
| 2025-10-31 | Mr. Geoffrey Stuart CrowNon-Executive Chairman of the Board | 12,00M | 276,28k | Kauf | 0,02 | 22,00M | 120,00% |
| 2025-09-19 | Mr. David DicksonMD, CEO & Director | 250,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,51M | 11,05% |
| 2025-09-19 | Mr. David DicksonMD, CEO & Director | -75,88k | 0,00 | Other Derivative Disposition | - | - | - |